Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study [Phase 4]

View source ↗

Summary

This Phase 4 trial compared anti-Müllerian hormone–guided dosing to antral follicle count–guided dosing of recombinant FSH in infertility patients and has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant follicle-stimulating hormone (rFSH) (recombinant follicle-stimulating hormone)

Snippet

Sponsor: Vietnam National University | Conditions: Infertility | Phase 4 | Status: COMPLETED